Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · Real-Time Price · USD
1.400
+0.070 (5.26%)
Aug 6, 2026, 4:00 PM EDT - Market closed
Allarity Therapeutics Market Cap
Allarity Therapeutics has a market cap or net worth of $22.28 million as of August 7, 2026. Its market cap has increased by 42.04% in one year.
Market Cap
22.28M
Enterprise Value
23.96M
1-Year Change
42.04%
Ranking
Category
Stock Price
$1.40
ChartMarket Cap Chart
Since December 21, 2021, Allarity Therapeutics's market cap has decreased from $79.38M to $22.28M, a decrease of -71.94%. That is a compound annual growth rate of -24.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 22.28M | 30.52% |
| Dec 31, 2025 | 17.07M | 229.00% |
| Dec 31, 2024 | 5.19M | 106.50% |
| Dec 29, 2023 | 2.51M | -40.12% |
| Dec 30, 2022 | 4.20M | -94.65% |
| Dec 31, 2021 | 78.43M | -1.20% |
| Dec 21, 2021 | 79.38M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Barinthus Biotherapeutics | 23.29M |
| Longeveron | 22.97M |
| Citius Pharmaceuticals | 21.44M |
| Neuphoria Therapeutics | 21.35M |
| Celularity | 21.25M |
| Polyrizon | 21.06M |
| Atossa Therapeutics | 20.58M |
| Cellectar Biosciences | 20.14M |